Thromboembolism: all 818 studies
Page 8 of 9. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill PatientsCompletedNCT00810784
- 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in ChinaCompletedNCT00799968Phase 4
- Nadroparin for the Initial Treatment of Pulmonary ThromboembolismCompletedNCT00796692Phase 4
- Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement SurgeryCompletedNCT00793234Phase 2
- Predicting Bleeding Risk on Anticoagulant Therapy for Venous ThromboembolismCompletedNCT00788736
- Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in ChinaCompletedNCT00781378Phase 4
- Screening for Occult Malignancy in Patients With Idiopathic Venous ThromboembolismCompletedNCT00773448Not applicable
- Total Knee Arthroplasty And Thromboembolism: A Comparison Between Two Surgical TechniquesCompletedNCT00755300
- Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant WomenCompletedNCT00745212
- Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid EndarterectomyTerminatedNCT00742612Phase 2
- Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)CompletedNCT00740987Phase 3
- Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)CompletedNCT00740493Phase 3
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture SurgeryCompletedNCT00721760Phase 3
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement SurgeryCompletedNCT00718224Phase 3
- Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted MobilityTerminatedNCT00714597Phase 3
- Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture SurgeryCompletedNCT00709904Phase 3
- Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of ColumbiaCompletedNCT00703274Phase 2
- Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral HemorrhageStatus unknownNCT00699465Phase 4
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement SurgeryCompletedNCT00697099Phase 3
- Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic DiseaseCompletedNCT00695942
- Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing ChemotherapyCompletedNCT00694382Phase 3
- Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic AnticoagulationStatus unknownNCT00691470Phase 2/3
- Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous ThrombosisCompletedNCT00689520Phase 4
- Frankfurt Thrombophilia RegistryCompletedNCT00683397
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal SurgeryCompletedNCT00679588Phase 3
- Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic CancerTerminatedNCT00662688Phase 3
- Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal CancerCompletedNCT00660205
- Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot StudyTerminatedNCT00655122Phase 4
- Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee ReplacementCompletedNCT00641732Phase 2
- Evaluation of Patients With Vena Cava Inferior ThrombosisCompletedNCT00631423
- Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor PatientsCompletedNCT00629447Not applicable
- Retrospective Study to Review Patients at Risk for VTE at Hospital DischargeCompletedNCT00604370
- Venous Thrombosis in Turner SyndromeStatus unknownNCT00594763
- Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial FibrillationTerminatedNCT00580216Phase 3
- Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)WithdrawnNCT00541320Phase 2
- Venous Thromboembolism Taskforce Audit ProgramCompletedNCT00535171
- Dalteparin in Preventing Blood Clots in Patients With Lung CancerStatus unknownNCT00519805Phase 3
- Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.CompletedNCT00511784
- Sleep Apnea and Tromboembolic DiseaseStatus unknownNCT00501358
- Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU PatientsTerminatedNCT00493896Phase 3
- Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke IncidenceCompletedNCT00486915Not applicable
- Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung CancerCompletedNCT00476216Phase 1
- Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00462852Phase 2
- Epidemiology of Venous ThromboembolismCompletedNCT00456196
- A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical PatientsCompletedNCT00451412Phase 3
- Thromboprophylaxis and Bariatric SurgeryStatus unknownNCT00444652Phase 4
- Statins to Reduce D-dimer Levels in Patients With Venous ThrombosisTerminatedNCT00437892Phase 2
- Thromboprophylaxis in Critically Ill PatientsTerminatedNCT00437697Phase 4
- Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsCompletedNCT00433602
- PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.Status unknownNCT00432796Phase 3
- Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee ReplacementCompletedNCT00408239Phase 2
- An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging StudyCompletedNCT00402467Phase 2
- Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip ReplacementCompletedNCT00398905Phase 2
- Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip ReplacementCompletedNCT00396786Phase 2
- Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein ThrombosisCompletedNCT00395772Phase 2
- A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth ControlCompletedNCT00377988
- Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus ErythematosusCompletedNCT00371501Phase 4
- Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee ReplacementCompletedNCT00362492Phase 4
- Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement.CompletedNCT00361894Phase 3
- Screening for Occult Malignancy in Idiopathic Venous ThromboembolismCompletedNCT00361647Not applicable
- The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With EnoxaparinStatus unknownNCT00354796
- Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)CompletedNCT00353678Phase 2
- Dose Ranging Study in Elective Total Hip Replacement SurgeryCompletedNCT00338897Phase 2/3
- Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for SurgeryTerminatedNCT00338585Phase 3
- Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese PatientsCompletedNCT00333021Phase 3
- Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip ReplacementCompletedNCT00332020Phase 3
- Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00331838Phase 2
- Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart AttacksCompletedNCT00331071
- Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to EnoxaparinCompletedNCT00329628Phase 3
- ARIXTRA Local Study For Registration In China.CompletedNCT00328939Phase 3
- Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative CareTerminatedNCT00303407
- HTRS TE Registry (ThromboEmbolism Registry)CompletedNCT00266994
- D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of RecurrenceCompletedNCT00266045
- D-dimer to Establish Duration of Anticoagulation After Venous ThromboembolismCompletedNCT00264277Phase 4
- Understanding Risk Factors Involved in Developing a Second Blood Clot.Status unknownNCT00261014
- A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having SurgeryCompletedNCT00260988Phase 2/3
- Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed GliomasCompletedNCT00253669
- The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKORStatus unknownNCT00247702Not applicable
- S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial FibrillationCompletedNCT00244426Phase 3
- Aspirin for the Prevention of Recurrent Venous ThromboembolismStatus unknownNCT00222677Phase 2/3
- CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)CompletedNCT00219973Phase 3
- Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic EventsTerminatedNCT00206089Phase 3
- Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation CareCompletedNCT00205400Not applicable
- Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by WarfarinCompletedNCT00203658Phase 4
- Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)CompletedNCT00203580Phase 4
- The Roles of Tissue Factor in Malignant GliomasCompletedNCT00201903
- Study of IVC Filter Retrieval With the Günther Tulip Vena Cava FilterCompletedNCT00196118Phase 4
- Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung CarcinomaStatus unknownNCT00192829
- Fixed Dose Heparin StudyCompletedNCT00182403Phase 3
- PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)CompletedNCT00182364Phase 3
- Safety of a Diagnostic Strategy With D-Dimer Testing for PECompletedNCT00182221Phase 3
- PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)CompletedNCT00182143Phase 3
- Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)TerminatedNCT00149357
- Michelangelo - Oasis 5CompletedNCT00139815Phase 3
- Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour PatientsCompletedNCT00135876Phase 3
- Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)CompletedNCT00119457Phase 2
- Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing SurgeryCompletedNCT00096590
- Clotting Genetic Variants, Hormones, and Venous ThrombosisCompletedNCT00094185
- PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)CompletedNCT00077805Phase 4
- EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged ImmobilizationCompletedNCT00077753Phase 4